Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	66.61	124.75	74.87
Graham Fair Price	-19.56	4.54	5.64
PEG	13.49	-0.89	-1.02
Price/Book	-10.48	3.12	3.49
Price/Cash Flow	4265.30	-3766.58	86.28
Prices/Earnings	45.07	34.69	23.91
Price/Sales	66.84	46.63	27.95
Price/FCF	4265.30	-3766.58	86.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.03	0.55	0.67
Operating Margin	8.29	0.35	0.32
ROA	-37.45	0.02	0.03
ROE	0.04	0.02	-38.29
ROIC	0.03	0.02	-48.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.11	7.94
Dividends QOQ	0.15	0.62	313.12
EBIT QOQ	-0.47	-0.41	13.82
EPS QOQ	-0.23	-0.39	-67.70
FCF QOQ	2.93	-1.02	-65.12
Revenue QOQ	-0.39	-0.45	-15.26
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	325.33	496.07	52.48
Days Sales Outstanding (DSO)	164.83	261.83	58.85
Inventory Turnover	0.28	0.18	-34.42
Debt/Capitalization	0.08	0.09	8.41
Quick Ratio	2.95	2.68	-9.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.23	6.38	2.40
Cash	2.75	2.37	-14.00
Capex	-0.12	-0.06	49.71
Free Cash Flow	0.25	< 0.005	-97.90
Revenue	0.78	0.43	-45.06
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.61	4.01	10.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.03	-0.14	380.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating